drug · small molecule
patient view →glyburide
Phase 3updated 2mo agoby $ETON Eton Pharmaceuticals, Inc.🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for diabetes mellitus and type 2 diabetes mellitus and 8 investigational indications.
indications
indications
Type 2 Diabetes
targets
Sulfonylurea receptor 1, Kir6.2
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that